BSX Boston Scientific Corporation

42.99USD-1.49%Mkt Cap: 62.31B USDP/E: 18.14

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offe…

Insiders, last 90 days1 buy
Institutional holders20 on file

Key Statistics

Company
Market Cap62.31B USD
Enterprise Value74.84B USD
Revenue (TTM)21.07B USD
Gross Profit13.85B USD
Net Income (TTM)2.90B USD
Revenue/Share14.32 USD
Last Price42.99 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees59.0K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)18.14
P/E (Forward)13.73
PEG0.73
EV/EBITDA13.44
EV/Revenue3.55
P/S2.96
P/B2.43
EPS (TTM)2.37 USD
EPS (Forward)3.13 USD
52W Range
39.575% of range102.71
52W High102.71 USD
52W Low39.57 USD
Profitability
Gross Margin69.01%
Oper. Margin19.64%
EBITDA Margin26.44%
Profit Margin14.44%
ROE11.96%
ROA6.64%
ROIC10.00%
ROCE10.39%
Growth
Revenue Growth1.40%
Earnings Growth-21.50%
Cash Flow & Leverage
Operating CF4.53B USD
CapEx (TTM)1.13B USD
FCF Margin11.83%
FCF Yield4.00%
Net Debt11.34B USD
Net Debt/EBITDA2.04
Net Debt/FCF4.55
Balance Sheet
Debt/Equity0.47
Current Ratio1.36
Quick Ratio0.62
Book Value/Sh17.68 USD
Cash/Share0.42 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split2:1
Split DateNov 6, 2003
Analyst Consensus
Rating1.9 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)49.60 USD
Upside (mean)+15.4%
Target Range41.00 USD – 60.00 USD
41.00+15.4% to mean60.00
# Analysts28
Ownership
Shares Out.1.45B
Float1.44B
Insiders0.31%
Institutions96.92%
Short Interest
Short Ratio1.9d
Short % Float2.43%
Short % Out.2.42%
Shares Short35.11M
Short (prev mo.)41.41M
Technical
SMA 5043.93 (-2.1%)
SMA 20053.89 (-20.2%)
Beta0.58
S&P 52W Chg12.08%
Avg Vol (30d)17.63M
Avg Vol (10d)17.36M
Technical Indicators
RSI (14)45.4
MACD-0.1909
MACD Signal-0.0858
MACD Hist.-0.1052
BB Upper46.28 USD
BB Middle44.01 USD
BB Lower41.74 USD
BB Width10.32%
ATR (14)1.592 USD
Vol Ratio (20d)0.80x

About Boston Scientific (NYSE: BSX)

›

Boston Scientific (NYSE: BSX) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 59,000 employees.

The shares were at 42.99 USD on 19 November 2026, down 58.1% over 52 weeks. Its 52-week range is 39.57 USD to 102.71 USD: the price is 58.1% below the high and 8.6% above the low.

At a market capitalisation of 62.31B USD, it trades at 18.1 times trailing earnings and 13.7 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.6, a discount of 29% for BSX.

Boston Scientific reports return on equity of 12.0%, an operating margin of 19.6% and revenue up 1.4% year over year.

Its debt exceeds its cash by 11.34B USD, a debt-to-equity ratio of 0.47. Its Piotroski F-score is 9 out of 9, a strong reading of its financial health. 28 analysts cover the stock, with an average rating of Buy; their mean price target of 49.60 USD is 15.4% above the current price. The next earnings report is expected on 10 February 2027.